Ten large-cap stocks experienced significant declines during the week of February 23-27, 2026. Notable losers include First Solar (down 18.59% due to worse-than-expected Q4 results and below-estimate FY26 guidance), Zoom Communications (down 17.38% following mixed Q4 results and weak forward guidance), and Novo Nordisk (down 6.59% after announcing Chinese trial results and potential price cuts for Ozempic and Wegovy). Other major decliners include Donaldson, TopBuild, Corebridge Financial, Nu Holdings, KKR, Korea Electric Power, and Pure Storage.

Zacks Investment Research identifies three undervalued 'old economy' stocks using PEG ratio screening: Barclays (BCS), a UK bank with a 0.9 P/B ratio and 16% profit growth; Korea Electric Power (KEP), a power services company with an extremely low 3.4 P/E ratio; and Deutsche Bank (DB), a German bank with 0.8 P/B ratio, expected 18.9% earnings growth in 2026, and a planned 50% dividend increase.

Ten large-cap stocks were top performers last week, led by precious metals and semiconductor companies. Hecla Mining gained 29.31% amid geopolitical tensions and weakening US dollar, while First Majestic Silver rose 26.57%. Moderna jumped 17.44% following positive cancer vaccine trial data. Micron Technology gained 13.21% after analyst coverage initiation. Other gainers included Venture Global (21.6%), New Gold (24.03%), Coeur Mining (23.13%), Korea Electric Power (15.29%), and United Microelectronics (13.82%).

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday. Shares of Applied Digital Corporation (NASDAQ: APLD) fell sharply in today’s pre-market trading after the company reported worse-than-expected third-quarter financial results. Applied Digital posted a quarterly loss of 24 cents per share, versus a year-ago loss of 10 cents per share. The company’s quarterly sales came in at $43.35 million versus expectations of $51.92 million, according to data from Benzinga ...

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday. Shares of Walmart Inc. (NYSE: WMT) rose in today’s session after the company reported better-than-expected fourth-quarter financial results. Walmart reported fourth-quarter FY24 net sales growth of 5.7% year-over-year to $173.39 billion, beating the consensus of $170.71 billion. Adjusted EPS was $1.80, beating the consensus of $1.65. The board approved an annual cash dividend for fiscal year 2025 of 83 cents per share on a post-stock split basis or $2.49 per share on a pre-split basis, approximately a 9% increase from the $2.28 per share paid for the last fiscal year. Walmart shares gained 4.9% to $178.66 on Tuesday. Here are some other big stocks recording gains in today’s session. Iovance Biotherapeutics, ...

As of Feb. 8, 2024, four stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. Korea Electric Power ...

As of Nov. 27, 2023, five stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. Via Renewables, Inc. (NASDAQ: VIA) Via Renewables posted a profit for the third quarter. "Via was able to navigate one of the hottest ERCOT summers on record due to our proven risk management policies and portfolio diversification. We've been able to stay financially flexible while paying down debt and boosting liquidity since last quarter," said ...

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session. Gorilla Technology Group Inc. (NASDAQ: GRRR) shares fell 66% to $4.0150. Ensysce Biosciences, Inc. (NASDAQ: ENSC) tumbled 23.6% to $5.19. Ensysce Biosciences posted a Q4 loss of $1.52 per share. AST SpaceMobile, Inc. (NASDAQ: ASTS) shares dropped 21.2% to $5.04 after the company posted a wider Q4 loss. Annovis Bio, Inc. (NYSE: ANVS) fell 20.4% to $16.00. Annovis Bio received interim analysis for sample size re-estimation for its Phase 3 clinical trial for treatment ...

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,764.50 while the NASDAQ fell 0.49% to 11,324.28. The S&P 500 also fell, dropping, 0.21% to 3,943.00. Check This Out: Top 5 Materials Stocks That Could Lead To Your Biggest Gains In March   Leading and Lagging Sectors Utilities shares rose 0.7% on Thursday. Meanwhile, top gainers in the sector included Enel Chile S.A. (NYSE: ENIC), up 2%, and Korea Electric Power Corporation (NYSE: KEP), up 1%. In trading on Thursday, financial shares fell by 1.2%.   Top Headline Macy's, Inc. (NYSE: M) reported better-than-expected Q4 adjusted EPS and sales results and issued guidance. Macy's reported a sales decline of 4.6% year-on-year to $8.26 billion, beating the consensus of $8.25 billion. Adjusted EPS of $1.88 beat the consensus of $1.57.   Equities Trading UP BioRestorative Therapies, Inc. (NASDAQ: BRTX) shares shot up 37% to $3.82 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company's metabolic ThermoStem program. Shares of Diversified Healthcare Trust (NASDAQ: DHC) got a boost, ...

Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. Jasper Therapeutics, Inc. (NASDAQ: JSPR) gained 257% to $1.70 after the company announced clinical data from a Phase I/II trial of briquilimab as a conditioning treatment in sickle cell disease and beta thalassemia. ReShape Lifesciences Inc. (NASDAQ: RSLS) shares jumped 142.3% to $16.34. Reshape Lifesciences recently announced a 1-for-50 reverse stock split. Lucira Health, Inc. (NASDAQ: LHDX) surged 68% to $0.1875 after the company announced it submitted an Emergency Use Authorization application to the FDA for OTC use of its COVID-19 & Flu test. Swvl Holdings Corp. (NASDAQ: SWVL) shares gained 43% to $0.1958 after the company reported commencement of strategic review process. Vivos Therapeutics, Inc. (NASDAQ: VVOS) jumped 41% to $0.5678. Vivos Therapeutics recently posted a Q3 loss of $0.26 per share. EpicQuest Education Group International Limited (NASDAQ: EEIQ) gained 40.1% to $3.0962. Scilex Holding Company (NASDAQ: SCLX) jumped 40.1% to $5.59. Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) surged 33.8% to $0.6690. Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) gained 33.4% to $5.76. Aurinia said LUPKYNIS® (voclosporin) patent challenge settlement has been reached with Sun Pharmaceuticals. Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) rose 33.3% to $0.28. Navidea Biopharmaceuticals announced the notice of allowance for U.S. patent application for key component of the company's cancer immunotherapy pipeline. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) gained 32% to $4.24 after the company reported top-line results from the CM-101 Phase 2a liver fibrosis biomarker trial in NASH patients. The trial met its primary endpoint. RedHill Biopharma Ltd. (NASDAQ: RDHL) jumped 29% to $0.1810 after the company announced publication of data from the Phase 2 data study of RHB-107 in non-hospitalized COVID-19 patients. The study met the primary endpoint of safety and tolerability. ACM Research, Inc. (NASDAQ: ACMR) gained 28.7% to $9.92 after the company issued FY23 revenue guidance above estimates. Checkpoint Therapeutics, Inc. ...

U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today’s session. SoundHound AI, Inc. (NASDAQ: SOUN) shares dipped 19% to $1.43 after climbing around 72% on Friday. Inter & Co, Inc. (NASDAQ: INTR) dropped 17.7% to $1.9501. Mammoth Energy Services, Inc. (NASDAQ: TUSK) fell 17.3% to $7.15. Valens Semiconductor Ltd. (NYSE: VLN) declined 17% to $4.4800. PDS Biotechnology Corporation (NASDAQ: PDSB) fell 15.3% to $11.18. PDS Biotech announced exclusive global license agreement for investigational IL-12 tumor-targeted cytokine ...

Gainers Gorilla Technology Group Inc. (NASDAQ: GRRR) shares rose 162% to $21.30 in pre-market trading after jumping over 35% on Friday. Gorilla Technology recently said it is entering the MENA region with a security convergence offering in a multi-year, multi-million dollar deal. Swvl Holdings Corp. (NASDAQ: SWVL) shares rose 68% to $0.2302 in pre-market trading after the company reported commencement of strategic review process. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 49.1% to $0.2999 in pre-market trading. Novo Integrated Sciences recently announced receipt of notice from Nasdaq. Sorrento Therapeutics, Inc. (NASDAQ: SRNE) rose 33.2% to $1.18 in pre-market trading. Sorrento Therapeutics, last month, received FDA clearance to initiate clinical trials with a next generation mRNA vaccine against omicron SARS-CoV-2 virus. Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares rose 16.7% to $0.63 in pre-market trading. Unicycive recently reported termination of 'at-the-market' offering of shares of common stock. Cosmos Health Inc. (NASDAQ: COSM) rose 16% to $5.29 in pre-market trading. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market. Kala Pharmaceuticals, Inc. (NASDAQ: KALA) rose 14.1% to $43.53 in pre-market trading after gaining over 53% on Friday. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect. Senmiao Technology Limited (NASDAQ: AIHS) rose 14.1% to $1.03 in pre-market trading after declining around 4% on Friday. Aethlon Medical, Inc. (NASDAQ: AEMD) rose 12.6% to $0.31 in pre-market trading after gaining around 7% on Friday. Rubius Therapeutics, Inc. (NASDAQ: RUBY) rose 10.4% to $0.19 in pre-market trading after declining 9% on Friday. Cellectis S.A. (NASDAQ: ...